JP2007117181A - Soft capsule - Google Patents
Soft capsule Download PDFInfo
- Publication number
- JP2007117181A JP2007117181A JP2005309951A JP2005309951A JP2007117181A JP 2007117181 A JP2007117181 A JP 2007117181A JP 2005309951 A JP2005309951 A JP 2005309951A JP 2005309951 A JP2005309951 A JP 2005309951A JP 2007117181 A JP2007117181 A JP 2007117181A
- Authority
- JP
- Japan
- Prior art keywords
- capsule
- soft capsule
- hpmc
- hpc
- encapsulating material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 25
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 23
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 23
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 23
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 23
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims abstract description 22
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims abstract description 22
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims abstract description 8
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 239000002775 capsule Substances 0.000 abstract description 16
- 241001465754 Metazoa Species 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 108010010803 Gelatin Proteins 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000008273 gelatin Substances 0.000 description 10
- 229920000159 gelatin Polymers 0.000 description 10
- 235000019322 gelatine Nutrition 0.000 description 10
- 235000011852 gelatine desserts Nutrition 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 239000008393 encapsulating agent Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000006000 Garlic extract Substances 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229940055416 blueberry extract Drugs 0.000 description 2
- 235000019216 blueberry extract Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000020706 garlic extract Nutrition 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000021425 apple cider vinegar Nutrition 0.000 description 1
- 229940088447 apple cider vinegar Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
本発明は軟質カプセル剤に関し、更に詳しくは、被包材フィルムシートを2枚用いて製造される軟質カプセル剤に関する。 The present invention relates to a soft capsule, and more particularly to a soft capsule manufactured using two encapsulating film sheets.
カプセル剤の1種として、所謂軟質カプセル剤があり、その殆どが被包剤(カプセル剤)としてゼラチンを使用していて、その代表的な製造方法は、液状、ペースト状、粉末状等の内容物を、ゼラチンに通常グリセリンやソルビトール等の多価アルコールを加えて塑性を増した被包材で被包し、一定の形状に温熱下成形する方法である。 One type of capsule is a so-called soft capsule, most of which uses gelatin as an encapsulant (capsule), and its typical production method is liquid, pasty, powdery, etc. This is a method in which a product is encapsulated with an encapsulating material that is increased in plasticity by adding a polyhydric alcohol such as glycerin or sorbitol to gelatin, and then molded into a certain shape under heat.
即ち2枚の被包材フィルムシートの間に内容物を充填し、この2枚の被包材フィルムシートを加圧、加熱により溶融接着せしめ、裁断、乾燥して製造する方法である。 That is, the contents are filled between two encapsulating film sheets, and the two encapsulating film sheets are melt bonded by pressing and heating, and are cut and dried.
しかし乍ら、従来被包材として使用するゼラチンは、牛、豚、鳥類、魚類等の動物を出発原料として製造されており、その本質は蛋白質であるため、アレルギーの原因物質となったり、病原性蛋白分子の除去を必要とし、その除去が困難であるという難点がある。またゼラチンをはじめとする従来のカプセル被包材は熱可逆性ゲル(ローセットゲル)が主体であるため、温度による影響をうけやすく、製品流通時の温度変化や高温の保存条件下で変形や内容物の溶出などの欠点があった。 However, gelatin, which is conventionally used as an encapsulating material, is manufactured from animals such as cattle, pigs, birds, and fish, and its essence is a protein. There is a drawback that it is necessary to remove the sex protein molecule and it is difficult to remove it. In addition, since conventional capsule encapsulating materials such as gelatin are mainly thermoreversible gels (rosset gels), they are easily affected by temperature, and can be deformed under temperature changes during product distribution and storage conditions at high temperatures. There were defects such as elution of the contents.
また軟質カプセル被包材として使用されるこのゼラチンは、熱や光、着色剤(たとえばカラメル)、天然(動物)由来の原料等に基ずくの複雑な作用がからみ合って、時間がたてばその溶解性が段々小さくなり、その結果崩壊遅延を生ぜしめ易い材料である。事実たとえばブルーベリー、ニンニク、ミネラル類、アスコルビン酸等では崩壊遅延を生じることが多い。 In addition, this gelatin used as a soft capsule encapsulating material is entangled with complex actions based on heat, light, colorants (eg caramel), natural (animal) derived materials, etc. It is a material whose solubility is gradually reduced, and as a result, it tends to cause a collapse delay. In fact, for example, blueberries, garlic, minerals, ascorbic acid and the like often cause a delayed decay.
なお最近、植物由来のプルランを硬質カプセルの被包材として時として使用される場合があるが、硬質カプセルの内容物の品質保持性能に於いて、従来品のゼラチン等に比し大きく低下する。このためプルランは従来軟質カプセルの被包材としては使用されたことはない。 Recently, plant-derived pullulan is sometimes used as an encapsulating material for hard capsules, but the quality retention performance of the contents of hard capsules is greatly reduced compared to conventional gelatin and the like. For this reason, pullulan has never been used as a material for soft capsules.
本発明が解決しようとする課題は、従来の軟質のカプセル剤の上記難点を解決することであり、更に詳しくは動物に由来しない原料を使用し、崩壊遅延が少なく、温度耐性の秀れた且つ安定した品質の被包材を用いた軟質カプセル剤を新たに開発することである。 The problem to be solved by the present invention is to solve the above-mentioned drawbacks of conventional soft capsules, more specifically, using raw materials not derived from animals, having little decay delay, and having excellent temperature resistance and It is to develop a new soft capsule using a stable quality encapsulant.
この課題は、軟質カプセル剤に関し、ヒドロキシプロピルセルローズ及び/又はヒドロキシプロピルメチルセルロースなる被包材を使用することにより解決される。 This problem is solved with respect to soft capsules by using an encapsulant made of hydroxypropylcellulose and / or hydroxypropylmethylcellulose.
本発明に於いて使用される被包材としては、ヒドロキシプロピルセルローズ(以下HPCという)及び/又はヒドロキシプロピルメチルセルロース(以下HPMCという)である。 The encapsulating material used in the present invention is hydroxypropyl cellulose (hereinafter referred to as HPC) and / or hydroxypropyl methylcellulose (hereinafter referred to as HPMC).
ヒドロキシプロピルセルロースは界面活性能がある高分子物質で可食性フィルム形成剤、コーティング剤、保護コロイド剤、泡安定剤、乳化安定剤(水中油型)、分散剤、増粘剤などとして優れた機能を有する。水溶液を加熱すると粘度が上がりゲル化するが、冷却すると元の溶液状態に戻る。しかし乍らこのヒドロキシプロピルセルロースは従来軟質カプセル剤の被包材として使用されたことはない。 Hydroxypropyl cellulose is a high molecular weight material with surface activity and has excellent functions as an edible film forming agent, coating agent, protective colloid agent, foam stabilizer, emulsion stabilizer (oil-in-water type), dispersant, thickener, etc. Have When the aqueous solution is heated, the viscosity increases and gels, but when it is cooled, it returns to the original solution state. However, this hydroxypropyl cellulose has never been used as an encapsulating material for soft capsules.
本発明に於いて使用されるヒドロキシプロピルメチルセルロース(以下HPMCという)は[C6H7O2(OH)X(COH3)Y(OCH)2CHOHCH3)Z]nで表される化合物であって、被置換構造部の分子量は162.14であり、置換度1.19では分子量約180、置換度2.37では約210、nが約70では分子量13,000、nが約1000では約200,000のものである。 Hydroxypropyl methylcellulose (hereinafter referred to as HPMC) used in the present invention is a compound represented by [C 6 H 7 O 2 (OH) X (COH 3) Y (OCH) 2 CHOHCH 3 ) Z ] n The substituted structure has a molecular weight of 162.14, a molecular weight of about 180 at a substitution degree of 1.19, about 210 at a substitution degree of 2.37, a molecular weight of 13,000 at an n of about 70, and a molecular weight of about 200 at an n of about 1000. , 000.
このヒドロキシプロピルメチルセルロース(HPMC)は、セルロースのメチル及びヒドロキシプロピルの混合エーテルであり、セルロース繊維をカセイソーダ、塩化メチル、プロピレンオキシドと反応させることにより調製される。 This hydroxypropyl methylcellulose (HPMC) is a mixed ether of methyl and hydroxypropyl cellulose and is prepared by reacting cellulose fibers with caustic soda, methyl chloride, propylene oxide.
我が国に於いては、日本薬局方第二部に収載(第10改正(昭和56年4月告示)より収載)されており、錠剤、顆粒剤のコーティング剤、結合剤、シロップの懸濁安定剤、パップ剤の増粘剤、保水剤及び軟骨として使用されている。しかしこのHPMCも軟質カプセルの被包材としては従来使用されたことはない。 In Japan, it is listed in the second part of the Japanese Pharmacopoeia (listed from the 10th revision (announced in April 1981)), tablet, granule coating agent, binder, syrup suspension stabilizer. , Used as a thickener for poultices, water retention agent and cartilage. However, this HPMC has never been used as an encapsulating material for soft capsules.
本発明者は従来の軟質カプセル剤の被包材の難点を解消するには、従来のゼラチン以外の被包材を新たに開発することが、極めて重要であることを認識し、長年に亘る研究の結果、このHPC及び/又はHPMCが極めて優れた軟質カプセル剤の被包材となりうるものであることを見出し、本発明を完成したものである。 The present inventor has recognized that it is extremely important to develop a new encapsulating material other than the conventional gelatin in order to eliminate the difficulty of the encapsulating material of the conventional soft capsule, and many years of research As a result, the inventors have found that this HPC and / or HPMC can be a very excellent soft capsule encapsulating material, and have completed the present invention.
本発明に於いては、すでにのべた通り、HPC及びHPMCを夫々単独でまたは併用して使用する場合を包含するが、とくにHPCとHPMCとを特定の割合で使用する場合は、その相乗作用により、得られる軟質カプセルの酸素バリア性が著しく向上する。この際の割合(重量%)はHPC:HPMCが95.0:5.0〜99.9:0.1又は5.0:95〜0.1:99.9好ましくは99.0:1.0〜99.9:0.1又は1.0:99.0〜0.1:99.9である。この範囲外では相乗作用は期待できない。 In the present invention, as described above, the case where HPC and HPMC are used alone or in combination is included, but particularly when HPC and HPMC are used in a specific ratio, the synergistic action is caused. Thus, the oxygen barrier property of the obtained soft capsule is remarkably improved. In this case, the ratio (% by weight) of HPC: HPMC is 95.0: 5.0 to 99.9: 0.1 or 5.0: 95 to 0.1: 99.9, preferably 99.0: 1. 0-99.9: 0.1 or 1.0: 99.0-0.1: 99.9. Outside this range, synergy is not expected.
また本発明に於いては、HPC及び/又はHPMCに更に第3成分として有機酸を添加することが出来る。この第3成分の添加により、耐酸性が著しく向上する。 In the present invention, an organic acid can be further added as a third component to HPC and / or HPMC. By adding this third component, the acid resistance is remarkably improved.
この際の有機酸としては、代表的にはクエン酸、リンゴ酸、フマール酸、酒石酸、アスコルビン酸等を好ましいものとして例示出来る。その使用量はHPC又は/及びHPMC100重量部に対し通常0.1〜3.0である。 Typical examples of the organic acid in this case include citric acid, malic acid, fumaric acid, tartaric acid, ascorbic acid and the like. The amount used is usually 0.1 to 3.0 with respect to 100 parts by weight of HPC and / or HPMC.
本発明に於いては、被包材を用いて軟質カプセル剤を製造する方法自体は、従来の方法を用いて行えば良く、その代表例を示せば従来のロータリー型カプセル充填機を用いる方法が例示出来る。 In the present invention, the method itself for producing a soft capsule using an encapsulating material may be performed using a conventional method, and a representative example thereof is a method using a conventional rotary capsule filling machine. It can be illustrated.
本発明に於いては被包材には必要に応じて他のゲル化剤や添加剤を加えることが出来、たとえばゼラチン、海藻エキス、寒天、色素、魚燐箔などのパール化剤、各種ビタミン等を例示できる。 In the present invention, other gelling agents and additives can be added to the encapsulating material as required, for example, pearlizing agents such as gelatin, seaweed extract, agar, pigment, fish phosphorus foil, various vitamins, etc. Etc. can be illustrated.
本発明に於いて、HPC及び/又はHPMCを被包材としてカプセル剤となすが、この際のカプセル剤の内容物としては各種の成分が広く利用出来、ゼラチンでは崩壊遅延が生じ易いたとえば、ブルーベリー、ロイヤルゼリー、ニンニクエキス、ミネラル類、アスコルビン酸等も使用出来る。 In the present invention, HPC and / or HPMC is used as a capsule material to form a capsule, and various components can be widely used as the capsule contents at this time. Royal jelly, garlic extract, minerals, ascorbic acid, etc. can also be used.
本発明の被包材は、動物や植物に由来しているものではなく、崩壊遅延が生じ難く、工業的に安定して製造出来るものであり、このため従来のゼラチンの有する難点が全くなく、温度変化や高温下での保存条件下での難点が無くなり、極めて優れたカプセル剤を提供することが出来るものである。 The encapsulating material of the present invention is not derived from animals or plants, is less prone to decay delay, can be produced industrially stably, and therefore has no difficulty with conventional gelatin, There is no difficulty in storage conditions under temperature changes or high temperatures, and an extremely excellent capsule can be provided.
以下に実施例を用いて本発明を詳しく説明する。但し下記例に於いて%は重量%を示す。 Hereinafter, the present invention will be described in detail with reference to examples. However, in the following examples,% indicates% by weight.
HPC・・・・・・・・30%
グリセリン・・・・・・9%
水・・・・・・・・・・・・61%
上記の成分を所定割合で加温混合し、脱気後、ロータリー式カプセル充填機にかけ、展延、乾燥させながら、常法に従って製造したカプセル皮膜に、ブルーベリーのエキス末50%を含有する大豆油を充填して、内容量300mgの軟質カプセルとなした。このカプセルを40℃、RH75%の条件下に保存したうえ、水を溶媒として崩壊時間の変化を測定し、表1の結果を得た。
HPC ... 30%
Glycerin 9%
Water ... 61%
Soybean oil containing 50% blueberry extract powder in a capsule film produced according to a conventional method while heating and mixing the above ingredients at a predetermined ratio, degassing, applying to a rotary capsule filling machine, spreading and drying. Was filled into a soft capsule with an internal volume of 300 mg. The capsules were stored under conditions of 40 ° C. and RH 75%, and the change in disintegration time was measured using water as a solvent, and the results shown in Table 1 were obtained.
上記実施例1に於いて、使用した成分を下記の成分とし、その他は全て実施例1と同様に処理した。このときの崩壊時間の変化を同様に測定し、下記表1に併記した。 In Example 1 above, the components used were the following components, and all other components were treated in the same manner as Example 1. The change in disintegration time at this time was measured in the same manner, and is also shown in Table 1 below.
ゼラチン・・・・・・45%
グリセリン・・・・・5%
水・・・・・・・・・・・50%
Gelatin 45%
Glycerin 5%
Water: 50%
上記実施例1に於いて、使用した成分を下記の成分とし、その他は全て実施例1と同様に処理した。このときの崩壊時間の変化を同様に測定した。この結果は充填時12.0min、3ヶ月後11.4minであった。 In Example 1 above, the components used were the following components, and all other components were treated in the same manner as Example 1. The change in the decay time at this time was measured in the same manner. The result was 12.0 min at filling and 11.4 min after 3 months.
HPMC・・・・・・25%
ソルビトール・・・・5%
水・・・・・・・・・・・・70%
HPMC ... 25%
Sorbitol ... 5%
Water ... 70%
上記実施例1に於いて、ブルーベリーのエキス粉に代えて、ニンニクエキス末を使用し、その他は全て実施例1と同様に処理した。またこのとき崩壊時間を測定した所、充填時13.0min、2ヶ月後12.8minであった。 In Example 1 above, garlic extract powder was used in place of the blueberry extract powder, and everything else was processed in the same manner as Example 1. Further, at this time, the disintegration time was measured, and it was 13.0 min at filling and 12.8 min after 2 months.
HPC・・・・・・・・20%
水・・・・・・・・・・・・80%
上記2成分を夫々均質に加温混合し、脱気のうえロータリー式カプセル充填機付属のスプレッダーにて乾燥させながら展延し、常法により市販原料のDHA油(DHAとして46%を含有)を充填して内容量250mgの軟質カプセルを製し、40℃、RH75%の条件下で保存のうえ、充填物の過酸化物価(meq/kg)を経時的に測定して下記表2の結果を得た。
HPC ... 20%
Water ... 80%
The above two components are heated and mixed homogeneously, degassed and spread while drying with a spreader attached to a rotary capsule filling machine, and commercially available DHA oil (containing 46% as DHA) is obtained by a conventional method. Filled to make a soft capsule with an inner volume of 250 mg, stored under the conditions of 40 ° C. and RH 75%, and measured the peroxide value (meq / kg) of the filling over time. Obtained.
上記実施例4に於いて、HPC20%及び水80%に代えて、HPMC20%、水80%とし、その他は全て実施例4と同様に処理しカプセル剤を得た。このものの過酸化物価(meq/kg)を同様に測定した結果を表2に併記した。 In Example 4, instead of HPC 20% and water 80%, HPMC 20% and water 80% were used, and everything else was processed in the same manner as in Example 4 to obtain capsules. The results of measuring the peroxide value (meq / kg) of this product in the same manner are also shown in Table 2.
上記実施例4に於いて、使用した成分を下記成分とし、その他は全て実施例4と同様に処理し、同様に過酸化物価(meq/kg)を測定した。この結果を下記表2に示す。 In Example 4 above, the components used were the following components, and everything else was treated in the same manner as in Example 4 and the peroxide value (meq / kg) was measured in the same manner. The results are shown in Table 2 below.
HPC・・・・・・・19.5%
HPMC・・・・・・・0.5%
水・・・・・・・・・・・80.0%
HPC ... 19.5%
HPMC ... 0.5%
Water: 80.0%
HPMC・・・・19.5%
HPC・・・・・・・・0.5%
水・・・・・・・・・・80.0%
HPMC ... 19.5%
HPC: 0.5%
Water: 80.0%
HPC・・・・・・・・22.5%
グリセリン・・・・・・2.0%
クエン酸・・・・・・・・0.5%
水・・・・・・・・・・・・75.0%
上記4成分を加温混合し、脱気のうえロータリー式カプセル充填機にかけ展延、乾燥させながら、常法により市販のグレープシードオイルを充填して、内容量270mgの軟質カプセルを製した。このカプセルについて、水、人工胃液(PH1.2)及び人工腸液(PH6.8)を用いて夫々崩壊試験を行い表3の結果を得た。
HPC 22.5%
Glycerin ... 2.0%
Citric acid: 0.5%
Water ... 75.0%
The above four components were heated and mixed, degassed, spread on a rotary capsule filling machine, spread and dried, and then filled with commercially available grape seed oil by a conventional method to produce a soft capsule having an internal volume of 270 mg. The capsule was subjected to a disintegration test using water, artificial gastric fluid (PH1.2) and artificial intestinal fluid (PH6.8), and the results shown in Table 3 were obtained.
上記実施例8に於いてクエン酸を使用せず且つグリセリンを2.5%とし、その他は全て実施例8と同様に処理し、同様に崩壊試験を実施した。この結果を表3に併記した。 In Example 8 above, citric acid was not used and glycerin was adjusted to 2.5%, and the others were all treated in the same manner as in Example 8, and the disintegration test was conducted in the same manner. The results are also shown in Table 3.
上記実施例8に於いて下記に示す成分を用い、その他は全て実施例8と同様に処理して、軟質カプセルを製造した。このものの崩壊試験を同様に実施した。その測定結果を表4に示した。 In Example 8 above, the components shown below were used, and everything else was processed in the same manner as Example 8 to produce soft capsules. The disintegration test of this thing was similarly implemented. The measurement results are shown in Table 4.
HPMC・・・・・・22.0%
ソルビトール・・・・2.0%
リンゴ酢・・・・・・・・1.0%
水・・・・・・・・・・・・75.0%
HPMC 22.0%
Sorbitol ... 2.0%
Apple cider vinegar ... 1.0%
Water ... 75.0%
上記実施例10に於いて、リンゴ酸を使用せず且つ水76.0%とし、その他は全て実施例10と同様に処理して、軟質カプセルを調製した。このものの崩壊試験を同様に行った。この結果を表4に併記した。 In Example 10 above, malic acid was not used and the water content was 76.0%, and everything else was processed in the same manner as in Example 10 to prepare soft capsules. This was subjected to the same disintegration test. The results are also shown in Table 4.
Claims (3)
The soft capsule according to claim 1 or 2, further comprising an organic acid as a third component in the encapsulating material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005309951A JP2007117181A (en) | 2005-10-25 | 2005-10-25 | Soft capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005309951A JP2007117181A (en) | 2005-10-25 | 2005-10-25 | Soft capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2007117181A true JP2007117181A (en) | 2007-05-17 |
Family
ID=38141688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005309951A Pending JP2007117181A (en) | 2005-10-25 | 2005-10-25 | Soft capsule |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2007117181A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003004003A1 (en) * | 2001-07-05 | 2003-01-16 | Wakunaga Pharmaceutical Co., Ltd. | Soft capsules |
| JP2003506415A (en) * | 1999-08-05 | 2003-02-18 | ディメンショナル フーズ コーポレイション | Particularly edible products with holographs and methods and apparatus for producing them |
| JP2003526472A (en) * | 2000-03-17 | 2003-09-09 | スタネルコ ファイバー オプティックス リミテッド | capsule |
| WO2005077419A1 (en) * | 2004-02-17 | 2005-08-25 | Eisai Co., Ltd. | Soft capsule preparation |
| JP2005529645A (en) * | 2002-05-21 | 2005-10-06 | バイオプログレス・テクノロジー・インターナショナル・インコーポレイテッド | Powder compression and coating |
-
2005
- 2005-10-25 JP JP2005309951A patent/JP2007117181A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003506415A (en) * | 1999-08-05 | 2003-02-18 | ディメンショナル フーズ コーポレイション | Particularly edible products with holographs and methods and apparatus for producing them |
| JP2003526472A (en) * | 2000-03-17 | 2003-09-09 | スタネルコ ファイバー オプティックス リミテッド | capsule |
| WO2003004003A1 (en) * | 2001-07-05 | 2003-01-16 | Wakunaga Pharmaceutical Co., Ltd. | Soft capsules |
| JP2005529645A (en) * | 2002-05-21 | 2005-10-06 | バイオプログレス・テクノロジー・インターナショナル・インコーポレイテッド | Powder compression and coating |
| WO2005077419A1 (en) * | 2004-02-17 | 2005-08-25 | Eisai Co., Ltd. | Soft capsule preparation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4294862B2 (en) | Gelatin composition | |
| EP1117736B2 (en) | Modified starch film compositions | |
| EP1057862B1 (en) | Polymer film compositions for capsules | |
| JP5777625B2 (en) | Acid-resistant capsule | |
| EP1062274B1 (en) | Polyvinyl alcohol compositions | |
| KR101288079B1 (en) | Film-forming composition for soft capsules | |
| JP2003505565A (en) | Pullulan membrane composition | |
| CN1950072A (en) | Improved pullulan capsules | |
| EP1072633A1 (en) | Pullulan film compositions | |
| JP2000202003A (en) | Hard capsule and method for producing the same | |
| JP2005137935A (en) | Hard capsule and method for producing the same | |
| JP2007117181A (en) | Soft capsule | |
| JP7397886B2 (en) | Hard capsules with improved mechanical strength and oxygen permeability based on cellulose derivatives | |
| JP2004250369A (en) | Coating film composition for soft capsule | |
| CN103536928B (en) | Medicinal hollow hard capsule being primary raw material with inorganic montorillonite clay and preparation method thereof | |
| MXPA00002854A (en) | Gelatine compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Effective date: 20081003 Free format text: JAPANESE INTERMEDIATE CODE: A621 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20101021 |
|
| A131 | Notification of reasons for refusal |
Effective date: 20101116 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
| A02 | Decision of refusal |
Effective date: 20110315 Free format text: JAPANESE INTERMEDIATE CODE: A02 |